Author

H. E. Broxmeyer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

A. Fahey· 1 shared B. Ramdas· 1 shared C. M. Paulos· 1 shared C. Yao· 1 shared D. C. Link· 1 shared D. Henley· 1 shared E. R. Wolf· 1 shared G. Huang· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Fahey

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of human CD4+ T cell populations with distinct antitumor activity

M. H. Nelson, H. M. Knochelmann, S. R. Bailey, L. W. Huff, J. S. Bowers, K. Majchrzak, M. M. Wyatt, M. P. Rubinstein, S. Mehrotra, M. I. Nishimura, K. Armeson, P. G. Giresi, M. J. Zilliox, H. E. Broxmeyer, C. M. Paulos

The paper identifies human CD4+ T cell populations with distinct antitumor activity, showing CD26high T cells are epigenetically and transcriptionally different from Th17 cells and are more effective in tumor therapy.

bioRxiv · Dec 31, 2019Immunology

Mutant p53 Drives Clonal Hematopoiesis through Modulating Epigenetic Pathway

S. Chen, Q. Wang, H. Yu, M. L. Capitano, S. Vemula, S. C. Nabinger, R. Gao, C. Yao, M. Kobayashi, Z. Geng, A. Fahey, D. Henley, S. Z. Liu, E. R. Wolf, B. Ramdas, , Y. Liu

This study identifies mutant p53's role in promoting clonal hematopoiesis by modulating the EZH2-mediated epigenetic pathway.

bioRxiv · Apr 24, 2019Cancer Biology